08:48 AM EDT, 08/15/2024 (MT Newswires) -- Health care stocks were edging higher premarket Thursday with the Health Care Select Sector SPDR Fund (XLV) up 0.5% and the iShares Biotechnology ETF (IBB) recently inactive.

Incyte ( INCY ) and Syndax Pharmaceuticals ( SNDX ) said the US Food and Drug Administration has approved niktimvo to treat chronic graft-versus-host disease. Shares of Syndax Pharmaceuticals ( SNDX ) were up over 3% pre-bell.